<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0"><channel><title>Yahoo! Finance: NRT.AX News</title><copyright>Copyright (c) 2009 Yahoo! Inc. All rights reserved.</copyright><link>http://finance.yahoo.com/q/h?s=nrt.ax</link><description>Latest Financial News for NOVOGEN FPO</description><language>en-us</language><lastBuildDate>Tue, 1 Dec 2009 05:01:00 Etc/GMT</lastBuildDate><image><url>http://us.news2.yimg.com/us.yimg.com/p/fi/pr/40197.gif</url><title>Yahoo! Finance</title><link>http://finance.yahoo.com</link><width>144</width><height>17</height></image><item><title>Marshall Edwards, Inc. Appoints Acting CEO (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/091201/0564128.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/798207357</guid><pubDate>Tue, 1 Dec 2009 05:01:00 Etc/GMT</pubDate></item><item><title>Marshall Edwards, Inc.&apos;s NV-128, a Novel mTOR Inhibitor, Demonstrates Good Safety Profile and High Anti-Cancer Activity In Vivo (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090929/0541868.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/219185675</guid><pubDate>Tue, 29 Sep 2009 12:30:00 Etc/GMT</pubDate></item><item><title>Marshall Edwards, Inc. Receives Nasdaq Notice of Minimum Bid Price Non-Compliance (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090922/0539617.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/3153872667</guid><pubDate>Tue, 22 Sep 2009 13:03:00 Etc/GMT</pubDate></item><item><title>Marshall Edwards Licenses the Investigational Anti-Cancer Compound NV-128 From Novogen Limited (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090805/0524945.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/609588295</guid><pubDate>Wed, 5 Aug 2009 12:05:00 Etc/GMT</pubDate></item><item><title>Novogen Director Retires (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090730/0523400.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/2473201493</guid><pubDate>Thu, 30 Jul 2009 12:00:00 Etc/GMT</pubDate></item><item><title>Researchers Discover That Phenoxodiol Kills Rapidly Proliferating T-Cells (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090707/0516390.html?.v=2</link><description></description><guid isPermaLink="false">yahoo_finance/537041104</guid><pubDate>Tue, 7 Jul 2009 12:00:00 Etc/GMT</pubDate></item><item><title>Independent Data Monitoring Committee Reviews Marshall Edwards, Inc.&apos;s Arrangements for Data Analysis of the Ovature Trial (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090617/0511457.html?.v=2</link><description></description><guid isPermaLink="false">yahoo_finance/2765734427</guid><pubDate>Wed, 17 Jun 2009 12:30:00 Etc/GMT</pubDate></item><item><title>Novogen&apos;s NV-128 Targets the mTOR Pathway to Block Differentiation and Induce Cell Death in Ovarian Cancer Stem Cells (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090420/0492323.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/3314993356</guid><pubDate>Mon, 20 Apr 2009 12:00:00 Etc/GMT</pubDate></item><item><title>Marshall Edwards, Inc., to Undertake Analysis of Ovature Trial (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090414/0490810.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/4259506102</guid><pubDate>Tue, 14 Apr 2009 12:20:00 Etc/GMT</pubDate></item><item><title>Board Changes at Novogen Limited Announced (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090323/0484209.html</link><description></description><guid isPermaLink="false">yahoo_finance/2862946541</guid><pubDate>Mon, 23 Mar 2009 14:46:00 Etc/GMT</pubDate></item><item><title>Biotech Analyst Joins Board of Directors of Marshall Edwards, Inc. (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090319/0483546.html</link><description></description><guid isPermaLink="false">yahoo_finance/4282570651</guid><pubDate>Thu, 19 Mar 2009 17:06:00 Etc/GMT</pubDate></item><item><title>Novogen&apos;s NV-128 Targets the mTOR Pathway to Induce Cell Death in Epithelial Ovarian Cancer Stem Cells (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090318/0482948.html</link><description></description><guid isPermaLink="false">yahoo_finance/3817501339</guid><pubDate>Wed, 18 Mar 2009 15:15:00 Etc/GMT</pubDate></item><item><title>Triphendiol Safety Data Clears the Way for Compound to Be Studied Further in the Treatment of Pancreatic Cancer (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090318/0483016.html</link><description></description><guid isPermaLink="false">yahoo_finance/1007604282</guid><pubDate>Wed, 18 Mar 2009 13:21:00 Etc/GMT</pubDate></item><item><title>Yale Researchers Present Results of Phase II Phenoxodiol Clinical Trial in Prostate Cancer Patients at ASCO 2009 Genitourinary Cancers Symposium (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090224/0476788.html</link><description></description><guid isPermaLink="false">yahoo_finance/1227972256</guid><pubDate>Tue, 24 Feb 2009 13:00:00 Etc/GMT</pubDate></item><item><title>Novogen to Focus on Oncology Program (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090213/0474108.html</link><description></description><guid isPermaLink="false">yahoo_finance/2964823734</guid><pubDate>Fri, 13 Feb 2009 14:27:00 Etc/GMT</pubDate></item><item><title>Marshall Edwards, Inc. to Present at the 27th Annual JPMorgan Healthcare Conference (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090114/0465919.html</link><description></description><guid isPermaLink="false">yahoo_finance/3241829022</guid><pubDate>Wed, 14 Jan 2009 13:59:00 Etc/GMT</pubDate></item><item><title>Marshall Edwards, Inc. Granted IND for Triphendiol (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090107/0464148.html</link><description></description><guid isPermaLink="false">yahoo_finance/440096689</guid><pubDate>Wed, 7 Jan 2009 13:10:00 Etc/GMT</pubDate></item></channel></rss><!-- c12.finance.sp2.yahoo.com compressed/chunked Tue Dec 22 06:49:18 PST 2009 -->
